|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$135,464
|
$94,825
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-07S1
|
$37,430
|
$1,497
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$3,646
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$10,024
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$11,700
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
$62,400
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$128,700
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
5R01CA044722-25
|
$222,013
|
$111,007
|
STUDZINSKI, GEORGE
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S1
|
$218,356
|
$13,101
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S2
|
$203,848
|
$12,231
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S3
|
$86,197
|
$5,172
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
$130,200
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-15
|
$518,415
|
$51,842
|
HANDE, KENNETH
|
VANDERBILT UNIVERSITY
|
|
Validation of the Pre-BCR Signaling Complex in pre-B ALL Cell Model by Two-Color
|
1F31CA192848-01
|
$29,887
|
$29,887
|
ERASMUS, MICHAEL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Validation of PROMIS Measures in Children with Brain Tumors
|
5R01CA174452-04
|
$309,251
|
$309,251
|
LAI, JIN-SHEI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Validation and Development of WEE1 as a therapeutic target in AML
|
5R01CA172385-03
|
$316,050
|
$158,025
|
PORTER, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
Validating the prognostic value of EGFR768 in neuroblastoma
|
5R21CA187554-02
|
$204,076
|
$204,076
|
CHAN, EDWARD
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-07
|
$387,731
|
$387,731
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$183,605
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$374
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$10,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$5,449
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$3,028
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$1,271
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-02
|
$399,401
|
$399,401
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using game mechanics to improve outcomes among stem cell transplant survivors
|
2R42CA168107-02
|
$616,412
|
$616,412
|
MCLAUGHLIN, JEFFERY
|
RADIANT CREATIVE GROUP, LLC
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$24,139
|
$7,242
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S1
|
$62,500
|
$7,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S2
|
$50,000
|
$6,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-40
|
$6,231,178
|
$747,741
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$8,525
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$1,316,380
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
3U54CA096300-15S2
|
$400,000
|
|
TRAVIS, ELIZABETH
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Unleashing the Efficacy of PI3K/AKT/mTOR Pathway Inhibitors in B-ALL
|
5F32CA189629-02
|
$56,042
|
$56,042
|
VO, THANH-TRANG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S1
|
$247,355
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S2
|
$35,000
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S3
|
$124,862
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S4
|
$48,726
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S5
|
$174,039
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S6
|
$107,460
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
5P30CA044579-27
|
$2,599,349
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of New Mexico Cancer Center Support Grant
|
2P30CA118100-11
|
$1,900,889
|
$589,276
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S1
|
$113,250
|
$35,108
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S2
|
$50,000
|
$15,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S3
|
$250,000
|
$77,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S4
|
$125,000
|
$38,750
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S5
|
$172,654
|
$53,523
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S1
|
$113,625
|
$2,273
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
Total relevant funding to Childhood Cancers for this search: $228,410,119
|